EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases

Milena Fronza Broering, Pedro Leonidas Oseliero Filho, Pâmela Pacassa Borges iD, Luis Carlos Cides da Silva, Marcos Camargo Knirsch, Luana Filippi Xavier, Pablo Scharf, Silvana Sandri, Marco Antonio Stephano, Fernando Anselmo de Oliveira iD, Ibrahim M Sayed, Lionel Fernel Gamarra iD und 3 weitere

International Journal of Nanomedicine · 2024-04 · Volume 19 · 3537-3554

DOI: 10.2147/ijn.s451589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024-04. Verfasst von Milena Fronza Broering und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis, Silicon Dioxide. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesColitisSilicon DioxideHumansMiceAnimalsCaco-2 CellsInflammationPeptides

Stichwörter der Autor:innen

SBA-15annexin A1inflammationoral routetissue recovery

Substanzen

SBA-15PeptidesSilicon Dioxide

Autor:innen und Institutionen

  • Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil.
  • Department of Biomedical and Nutritional Sciences, University of Massachusetts, Lowell, MA, USA.
  • Department of Applied Physics, Physics Institute, University of Sao Paulo, São Paulo, Brazil.
  • Materials Innovation Factory, University of Liverpool, Liverpool, MSY, UK.
  • Department of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil.
  • Instituto do Cérebro, Instituto Israelita de Ensino e Pesquisa, Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo, SP, Brazil.

ORCID-Profile: Pâmela Pacassa Borges, Fernando Anselmo de Oliveira, Lionel Fernel Gamarra

Zitieren

APA

Broering, M. F., Oseliero Filho, P. L., Borges, P. P., da Silva, L. C. C., Knirsch, M. C., Xavier, L. F., Scharf, P., Sandri, S., Stephano, M. A., de Oliveira, F. A., Sayed, I. M., Gamarra, L. F., Das, S., Fantini, M. C. A., & Farsky, S. H. P. (2024). Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases. International Journal of Nanomedicine, Volume 19, 3537-3554. https://doi.org/10.2147/ijn.s451589

Vancouver

Broering MF, Oseliero Filho PL, Borges PP, da Silva LCC, Knirsch MC, Xavier LF, et al. Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases. International Journal of Nanomedicine. 2024;Volume 19:3537-3554. doi:10.2147/ijn.s451589

BibTeX
@article{Broering2024,
  author = {Broering, Milena Fronza and Oseliero Filho, Pedro Leonidas and Borges, Pâmela Pacassa and da Silva, Luis Carlos Cides and Knirsch, Marcos Camargo and Xavier, Luana Filippi and Scharf, Pablo and Sandri, Silvana and Stephano, Marco Antonio and de Oliveira, Fernando Anselmo and Sayed, Ibrahim M and Gamarra, Lionel Fernel and Das, Soumita and Fantini, Márcia C A and Farsky, Sandra H P},
  title = {Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  volume = {Volume 19},
  pages = {3537--3554},
  doi = {10.2147/ijn.s451589}
}
Kostenlos starten →